Treatment News : Voucher Incentives Draw Injection Drug Users Into HIV Care

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2014

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

May 28, 2014

Voucher Incentives Draw Injection Drug Users Into HIV Care

Providing voucher incentives can increase key rates of engagement into HIV care among injection drug users (IDUs) living with the virus, according to a small pilot study in India, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers recruited 120 HIV-positive IDUs in Chennai, India, between 2009 and 2010 and randomized them to either receive incentives for engagement in care or to serve as part of a control group.

The incentives amounted to vouchers worth about $4 to $8 that could be used for food or household items. They were provided when participants in the incentive arm attended monthly checkups, began taking antiretrovirals (ARVs) and achieved a fully suppressed viral load. While those in the control arm did not receive such incentives, they did have the chance to win vouchers as a part of a larger pool.

Compared with those in the control group, the members of the incentive group were significantly more likely to link to HIV care and to start ARVs sooner. Out of those in the study who received care at an ARV center, 45 percent in the incentive group started treatment compared with 27 percent of the control group. Vouchers were linked to a 2.93-fold increased likelihood of beginning treatment. Those in the incentive group had a median of eight monthly follow-up appointments in the yearlong study, compared with only four in the control group.

However, there was no association between vouchers and reaching a suppressed viral load: About a third of each study arm did so. The researchers state that this warrants future study.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: Injection drug users, IDUs, HIV, voucher incentives, aidsmap.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adorableone
    New York
    New York


    soy_Ric
    Rochester
    New York


    youngbloodlatino
    Columbia
    Maryland


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.